Cancer clinical trials in the region Auvergne-Rhône-Alpes
342 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Lymphoma
#NCT05463263
B cell lymphoma
T cell lymphoma
None
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Step Pharma, SAS
Phase 2
Kidney cancer
#NCT04299646
Clear cell carcinoma
Metastatic
1
2
0
1 or 2
Systemic Treatment-Naive
Immunotherapy
Targeted therapy
Centre de Radiothérapie Marie Curie (Valence)
Centre François Baclesse
Phase 2
Lung cancer
#NCT05742607
NSCLC (Non-Small Cell Lung Cancer)
Localized
None
Systemic Treatment-Naive
ALK
EGFR
Immunotherapy
Targeted therapy
Centre Léon Bérard (Lyon)
Innate Pharma
Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT04617756
Upper excretory tract cancer
Urothelial carcinoma
Localized
None
Systemic Treatment-Naive
Surgery
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Centre Hospitalier Universitaire de Nîmes
Phase 1 / Phase 2
Lung cancer
#NCT04626635
#2022-501234-37-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
1
2
3 or more
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
Immunotherapy
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
Regeneron Pharmaceuticals
Phase 1 / Phase 2
Lung cancer
#NCT04626635
#2022-501234-37-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
Immunotherapy
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
Regeneron Pharmaceuticals
Phase 1 / Phase 2
Colon cancer
Rectal cancer
#NCT04626635
#2022-501234-37-00
Cohortes E, F, I et J
Metastatic
MSS/pMMR
1
2
3 or more
Systemic Treatment-Naive
Immunotherapy
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
Regeneron Pharmaceuticals
Phase 1 / Phase 2
Lymphoma
#NCT05607420
#2022-501607-27-00
Partie escalade de dose
B cell lymphoma
Large B cell lymphoma
Primary mediastinal lymphoma
Mantel cell lymphoma
Follicular lymphoma
Marginal zone lymphoma
MALT lymphoma
Indolent transformed lymphoma
None
2
3 or more
Chemotherapy
Monoclonal antibodies
Systemic Treatment-Naive
Car-T
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Cellectis SA
Phase 1 / Phase 2
Lymphoma
#NCT05607420
#2022-501607-27-00
Partie extension de dose
B cell lymphoma
Large B cell lymphoma
Follicular lymphoma
Indolent transformed lymphoma
None
2
3 or more
Chemotherapy
Monoclonal antibodies
Systemic Treatment-Naive
Car-T
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Cellectis SA
Phase 1 / Phase 2
Lymphoma
#NCT06088654
#2023-506976-28-00
B cell lymphoma
Large B cell lymphoma
Mantel cell lymphoma
Follicular lymphoma
Marginal zone lymphoma
Indolent transformed lymphoma
Disseminated (stage III and IV)
None
CD20
2
3 or more
Monoclonal antibodies
Hôpital de la Croix Rousse - Hospices Civils de Lyon (Lyon)
Innate Pharma